Ep.34 The Case for remdesivir | Coronavirus Daily podcast

Coronavirus Weekly
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

This week, it was announced that the drug remdesivir, an antiviral medication developed by Gilead Sciences, had proven effective against COVID-19 in a major study. The drug was found to cut the time of patient recovery by an average of 4 days. Dr. Anthony Fauci has said that remdesivir will set a new “standard of care” for treatment of COVID-19. To learn more about the drug and the results of the study, Christina speaks with Dr. Terese Hammond, pulmonary critical care specialist and one of the principal investigators for the remdesivir trials.

Related show links:

Subscribe to “Coronavirus Daily”via Apple Podcasts | Spotify RSS

Bobby Gonzalez on social media: Instagram
Christina Pascucci on social media: Instagram | Twitter
KTLA Podcasts on social media: Instagram |Twitter 
More podcasts from KTLA: Frank Buckley Interviews | Spoken Dreams | The News Director’s Office | California Cooking | Rich On Tech | Diva Defined with Sheryl Lee Ralph | Home Made with Kirk Hawkins | Mama Mentality with Megan Telles | Keepin’ It Friel: Conversations on Recovery

Explore KTLA Podcasts

Corona Virus Daily Podcast

New episodes are released weekdays.

Most Popular

Latest News

More News